AACR 2022 – In vitro and in vivo properties of MDK-703, An Fc-peptide fusion IL-7Rαγc agonist unrelated in structure to IL-7

Written By Lara Wilson
Lara Wilson
Previous

PEGS Boston Summit 2022 - Discovery and Versatile Use of Peptide-Based Agonists of Hetero-Dimeric γc Cytokine Receptors
Next

SITC 2021 - Peptidyl IL-2/15Rβγc-restricted agonists, highly-attenuated and linked to anti-PD-1 antibodies to achieve selectivity and amplify potency in stimulating PD-1 high lymphocytes